Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
Inhibition of N-myristoyltransferase has been validated pre-clinically as a target for the treatment of fungal and trypanosome infections, using species-specific inhibitors. In order to identify inhibitors of protozoan NMTs, we chose to screen a diverse subset of the Pfizer corporate collection agai...
Main Authors: | Andrew S Bell, James E Mills, Gareth P Williams, James A Brannigan, Anthony J Wilkinson, Tanya Parkinson, Robin J Leatherbarrow, Edward W Tate, Anthony A Holder, Deborah F Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3335879?pdf=render |
Similar Items
-
N-myristoyltransferase1 and N-myristoyltransferase2 Exhibit Differential Substrate Specificity for HIV-Gag and HIV-Nef
by: Smith Charles, et al.
Published: (2005-12-01) -
The role of N-myristoyltransferase 1 in tumour development
by: Hong Wang, et al.
Published: (2023-12-01) -
QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
by: Letícia Santos-Garcia, et al.
Published: (2018-09-01) -
Inhibitor Trapping in N-Myristoyltransferases as a Mechanism for Drug Potency
by: Danislav S. Spassov, et al.
Published: (2023-07-01) -
Inhibition of N‐myristoyltransferase1 affects dengue virus replication
by: San Suwanmanee, et al.
Published: (2019-09-01)